Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

Adaptation capacities are necessary to cope with the brutal and drastic changes imposed by
the pandemic and its consequences. In Parkinson's disease, where there are routine situations
with difficulties adjusting to newness, patients in the current situation may be particularly
affected and present anxiety due to great difficulties in adaptation.

The repercussions in terms of symptoms (motor and non-motor) of the disease could be very
significant. In this population already widely exposed to anxio-depressive symptoms
(depression being a common symptom of Parkinson's disease, affecting up to 30 to 40% of
patients outside of crisis periods), we can expect a risk increased psychiatric
decompensation. The psychiatric consequences could not be limited to the current period but
also concern long-term patients, in particular if there is decompensation of other symptoms
of the disease (motors, complications linked to treatment, etc.).

The consequences of COVID-19 in these already fragile patients should be evaluated. It will
be important to appreciate the confinement consequences imposed on the patient on the course
and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is
lifted.

This is an observational, French multicenter study, of an uncontrolled cohort of parkinsonian
patients followed by doctors from Parkinson Expert Centers in hospitals.